Open access · CC-BY
via OpenAlex
NEUROD1 efficiently converts peripheral blood cells into neurons with partial reprogramming by pluripotency factors
Yoichi Saito, Mitsuru Ishikawa, Mahito Ohkuma, Jonathan Moody, Yo Mabuchi, Tsukasa Sanosaka, Yoshinari Ando, Takayuki Yamashita, Chung-Chau Hon, Jay W. Shin, Wado Akamatsu, Hideyuki Okano
Proceedings of the National Academy of Sciences · 2025 · ▲ 8 citations
Abstract
The direct reprogramming of cells has tremendous potential in in vitro neurological studies. Previous attempts to convert blood cells into induced neurons have presented several challenges, necessitating a less invasive, efficient, rapid, and convenient approach. The current study introduces an optimized method for converting somatic cells into neurons using a nonsurgical approach that employs peripheral blood cells as an alternative source to fibroblasts. We have demonstrated the efficacy of a unique combination of transcription factors, including NEUROD1, and four Yamanaka reprogramming factors (OCT3/4, SOX2, KLF4, and c-MYC), in generating glutamatergic neurons within 3 wk. This approach, which requires only five pivotal factors (NEUROD1, OCT3/4, SOX2, KLF4, and c-MYC), has the potential to create functional neurons and circumvents the need for induced pluripotent stem cell (iPSC) intermediates, as evidenced by single-cell RNA sequencing and whole-genome bisulfite sequencing, along with lineage-tracing experiments using Cre-LoxP system. While fibroblasts have been widely used for neuronal reprogramming, our findings suggest that peripheral blood cells offer a potential alternative, particularly in contexts where minimally invasive sampling and procedures convenient for patients are emphasized. This method provides a rapid strategy for modeling neuronal diseases and contributes to advancements in drug discovery and personalized medicine.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1073/pnas.2401387122
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Saito, Y., Ishikawa, M., Ohkuma, M., Moody, J., Mabuchi, Y., Sanosaka, T., Ando, Y., Yamashita, T., Hon, C., Shin, J.W., Akamatsu, W., & Okano, H. (2025). NEUROD1 efficiently converts peripheral blood cells into neurons with partial reprogramming by pluripotency factors. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.2401387122
Vancouver
Saito Y, Ishikawa M, Ohkuma M, Moody J, Mabuchi Y, Sanosaka T, et al. NEUROD1 efficiently converts peripheral blood cells into neurons with partial reprogramming by pluripotency factors. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2401387122.
BibTeX
@article{yoichi2025NEUROD,
title = {NEUROD1 efficiently converts peripheral blood cells into neurons with partial reprogramming by pluripotency factors},
author = {Yoichi Saito and Mitsuru Ishikawa and Mahito Ohkuma and Jonathan Moody and Yo Mabuchi and Tsukasa Sanosaka and Yoshinari Ando and Takayuki Yamashita and Chung-Chau Hon and Jay W. Shin and Wado Akamatsu and Hideyuki Okano},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2401387122},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Progress in Neurobiology 2022
Open access · CC-BY
Reprogramming neurons for regeneration: The fountain of youth
Research Square 2022
Preprint · CC-BY
Metadichol, A natural ligand for expression of Yamanaka reprogramming factors in somatic and primary cancer cell lines
Journal of Molecular Neuroscience 2026
Open access · CC-BY
Early Reprogramming Intermediates Enable Direct Neuronal Conversion Via NGN2
Research Square 2022
Preprint · CC-BY
Metadichol, A natural ligand for expression of Yamanaka reprogramming factors in somatic and primary cancer cell lines
Research Square 2022
Preprint · CC-BY
Metadichol, A natural ligand for expression of Yamanaka reprogramming factors in somatic and primary cancer cell lines
Stem Cell Reports 2020
Open access · CC-BY